Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.

High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. Cancer Res. 1998 Dec 15; 58(24):5701-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.